Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
Immatics

November 2025

Immatics Market Share Analysis for November 2025

Prof. Dr. med. Dirk Busch joined Immatics Scientific Advisory Board in 2021. Dirk Busch studied human medicine at the Universities of Mainz and Freiburg, and completed his doctor’s degree in medicine in 1993. Dirk Busch studied human medicine at the Universities of Mainz and Freiburg, and completed his doctor’s degree in medicine in 1993. This was followed by his residency and postdotoral studies at the Children’s Hospital of the University of Würzburg from 1994 until 1996 and at the Section of Infectious Diseases and Immunobiology at the Yale University in New Haven/USA from 1996 until 1999. From there he joined the Technical University of Munich (TUM) where he finished in 2005 his clinical specialization in Medical Microbiology and Infection Epidemiology, and started his own independent research work as principal investigator. He gained his habilitation from TUM in 2001. From 2004 until 2008 he was C3-Professor for Medical Microbiology and Immunology […]
Year Founded2000
Employees501 - 1000
Annual Revenue$50M - $75M
immatics.com
Immatics
Immatics (including company regionals)
  • immatics.com
    immatics.com
See more website traffic and engagement information

Immatics Revenue up to November 2025 is 50M - 75M

revenue generated by Immatics top domains

Immatics top domains revenue over 3 years

Revenue for Immatics top domains


Total visits to Immatics's top domains

Understand Immatics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Immatics's top domains

Analyze Immatics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Immatics's top domains

See how Immatics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Immatics

These are the website technologies, by industry, used by Immatics top domains

Advertising (10)

DoubleClick

DoubleClick

Widget (8)

Twemoji

Twemoji

Conversion & Analytics (6)

Google Analytics

Google Analytics

Audio Video Media (3)

YouTube

YouTube

More Technologies

9

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Immatics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsImmatics Biotechnologies GmbH hired Amie Krause as Chief Human Resources Officer on Oct 27th '25.Amie Krause joins Immatics from Dompé, where she served as Chief Human Resources Officer.
NewsImmatics Biotechnologies GmbH hired Venkat Ramanan as Chief Financial Officer on Oct 1st '25.Houston, Texas and Tuebingen, Germany, October 1, 2025 - Immatics N.V. (NASDAQ: IMTX, "Immatics" or the "Company"), a clinical-stage biopharmaceutical company and the global leader in precision targeting of PRAME, today announced the appointment of Venkat Ramanan, Ph.D., as Chief Financial Officer ("CFO"), effective immediately.
NewsImmatics Biotechnologies GmbH launches IMA203 TCR T-cell Therapy data at 2025 ASCO Annual Meeting.Immatics (NASDAQ: IMTX) has announced upcoming presentations of its IMA203 TCR T-cell therapy at the 2025 ASCO Annual Meeting in Chicago.

See all Immatics signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.